Detalhe da pesquisa
1.
Phase 1 Trial of a Therapeutic Anti-Yellow Fever Virus Human Antibody.
N Engl J Med
; 383(5): 452-459, 2020 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32726531
2.
An antibody engineering platform using amino acid networks: A case study in development of antiviral therapeutics.
Antiviral Res
; 192: 105105, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34111505
3.
Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
PLoS Negl Trop Dis
; 12(2): e0006209, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29425203
4.
Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates.
Antiviral Res
; 144: 44-47, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28529000